ABSTRACT
AIM: Increased left atrium diameter (LAD) is associated with elevated risk of cardiovascular morbidity and mortality. We evaluated new-onset left atrium enlargement (LAE) and their correlates over a 10-year period in participants of the general population enrolled in the Pressioni Monitorate e Loro Associazioni study. METHODS: The study included 1045 participants with normal LAD at baseline evaluation having a readable echocardiogram at the end of follow-up. Cut-points for abnormal LAD were derived from reference values recommended by American Society of Echocardiography. RESULTS: Over a 10-year period, 123 participants (11.8%) progressed to LAE. The incidence of new-onset LAE increased significantly from the lowest to the highest tertile of baseline office, home and 24-h blood pressure (BP); BMI; fasting blood glucose and left ventricular mass index (LVMI). In multivariate analysis, baseline LAD [odds ratio (OR) 3.18, confidence interval (CI) 2.26-4.47, Pâ<â0.001], female sex (OR 3.68, CI 2.20-6.18, Pâ<â0.001), office SBP (OR 1.36, CI 1.08-1.70, Pâ=â0.008), BMI (OR 1.35, CI 1.07-1.69, Pâ=â0.01 and LVMI (OR 1.29, CI 1.01-1.64, Pâ=â0.04) emerged as key correlates of new-onset LAE. CONCLUSION: The study shows that in the population, long-term changes from normal LAD to LAE are independently driven by several risk factors such as the female sex and an increased baseline LAD, BMI, LVMI and BP, with no predictive superiority of home and ambulatory versus office values. Preventing BP elevations, overweight/obesity and left ventricular hypertrophy may thus all be important for LAE prevention.
Subject(s)
Blood Pressure , Body Mass Index , Cardiomegaly/diagnostic imaging , Cardiomegaly/pathology , Adult , Aged , Blood Glucose/metabolism , Cardiomegaly/physiopathology , Cardiomegaly/prevention & control , Echocardiography , Female , Heart Atria/diagnostic imaging , Heart Atria/pathology , Heart Atria/physiopathology , Humans , Hypertrophy, Left Ventricular/prevention & control , Male , Middle Aged , Odds Ratio , Risk Factors , Sex FactorsABSTRACT
AIM: Data on the association of aortic root diameter (ARD), as assessed by echocardiography, with incident cardiovascular morbidity and mortality in the general population, are scanty and limited to elderly individuals. Thus, we investigated the value of ARD in predicting cardiovascular events in the Pressioni Arteriose Monitorate E Loro Associazioni population. METHODS: At entry, 1860 participants (mean age 50â±â14, 50.6% men) underwent diagnostic tests including laboratory investigations, office and out-of-office blood pressure (BP) measurements (home and 24-h ambulatory BP monitoring), and echocardiography. ARD was measured at the level of Valsalva's sinuses and indexed to body surface area and height. RESULTS: Over a follow-up of 148 months, 137 nonfatal or fatal cardiovascular events were documented. After adjustment for age, sex, BP, fasting blood glucose, total cholesterol, smoking status, previous cardiovascular disease, and use of antihypertensive drugs, ARD/height [hazard ratio for 1 unit increaseâ=â2.62, 95% confidence interval (CI) 1.19-5.75, Pâ=â0.01], but not absolute ARD (hazard ratio 1.44, 95% CI 0.89-2.39, Pâ=â0.13) neither ARD/body surface area (hazard ratio 2.09, 95% CI 0.96-4.55, Pâ=â0.06) predicted the increased risk of cardiovascular events. The association between left ventricular hypertrophy and AR dilatation was a stronger predictor of cardiovascular prognosis than left ventricular hypertrophy alone. CONCLUSIONS: Our results for the first time show that ARD indexed to height is predictive of incident nonfatal and fatal cardiovascular events among middle-aged individuals in the community and support the view that assessment of ARD in addition to left ventricular mass may refine cardiovascular risk stratification and preventive strategies in the general population.
Subject(s)
Aorta/pathology , Cardiovascular Diseases/etiology , Antihypertensive Agents/therapeutic use , Aorta/diagnostic imaging , Blood Pressure Monitoring, Ambulatory , Body Height , Body Surface Area , Cardiovascular Diseases/mortality , Echocardiography , Female , Follow-Up Studies , Humans , Hypertrophy, Left Ventricular/complications , Hypertrophy, Left Ventricular/diagnostic imaging , Male , Middle Aged , Organ Size , Prognosis , Proportional Hazards Models , Risk FactorsABSTRACT
OBJECTIVE: The risk of thoracic aortic dissection is strictly related to the diameter of the ascending aorta. Arterial hypertension represents a major risk factor for the development of aortic dissection and is thought to be directly involved in the pathogenesis of aortic aneurysms. Recent studies have suggested a high prevalence of aortic root enlargement in the hypertensive population, but evidence of a direct link between blood pressure values and size of the aortic root has been inconclusive so far. The aim of the current study was to evaluate prevalence of aortic root dilatation (ARD) in the hypertensive population and to assess the correlates of this condition. METHODS: Medical literature was reviewed to identify articles assessing prevalence of echocardiographic ARD in hypertensive patients. RESULTS: A total of eight studies including 10 791 hypertensive patients were considered. Prevalence of ARD in the pooled population was 9.1% with a marked difference between men and women (12.7 vs. 4.5%; odds ratio 3.15; 95% confidence interval 2.68-3.71). Hypertensive patients with ARD and those with normal aortic root size had similar office blood pressure values, but the former were older and had a significantly higher left-ventricular mass (0.52 SDs, 95% confidence interval 0.41-0.63). CONCLUSION: ARD is a common phenotype in hypertensive patients, with men showing a markedly higher susceptibility, but office blood pressure values do not appear to be directly associated with aortic root diameter.
Subject(s)
Aorta/diagnostic imaging , Heart Defects, Congenital/diagnostic imaging , Heart Valve Diseases/diagnostic imaging , Hypertension/complications , Aorta/physiopathology , Aortic Valve/diagnostic imaging , Bicuspid Aortic Valve Disease , Blood Pressure , Blood Pressure Determination , Dilatation, Pathologic/diagnostic imaging , Dilatation, Pathologic/epidemiology , Echocardiography , Female , Heart Defects, Congenital/epidemiology , Heart Defects, Congenital/etiology , Heart Valve Diseases/epidemiology , Heart Valve Diseases/etiology , Humans , Hypertension/epidemiology , Male , Prevalence , Risk FactorsABSTRACT
INTRODUCTION: The electrocardiogram (ECG) is listed among the routine diagnostic examinations for hypertensive patients according to international guidelines. OBJECTIVE: The aim of this survey was to investigate whether an ECG is routinely prescribed before an echocardiographic examination by general practitioners for the evaluation of subclinical cardiac damage in uncomplicated hypertensive patients in a suburban area of Italy. METHODS: A total of 60 consecutive hypertensive patients (45% men, mean age 60 ± 14 years) referred to a single out-patient cardiology service by their general practitioners for the assessment of cardiac organ damage by echocardiography were enrolled in the study. Patients' demographic data and medical history were collected at the echocardiographic laboratory on a questionnaire administered by the attending physician. RESULTS: Less than 40% of the study sample had undergone an ECG during the 12-month period preceding the echocardiographic examination. Notably, only 60% of newly diagnosed hypertensive patents had an ECG done after the discovery of their hypertensive status. CONCLUSIONS: These findings show that an ECG is not routinely prescribed as a first-line examination in the assessment of cardiac organ damage related to hypertension by a large fraction of general practitioners in current clinical practice in a northern area of Italy. This contrasts with available evidence that the combined assessment of left ventricular hypertrophy by ECG and echocardiogram provides the best evaluation of cardiac damage and stratification of cardiovascular risk in hypertension.
Subject(s)
Blood Pressure , Electrocardiography , Hypertension/diagnosis , Aged , Ambulatory Care , Echocardiography, Doppler , Female , General Practice , Health Care Surveys , Humans , Hypertension/complications , Hypertension/diagnostic imaging , Hypertension/physiopathology , Hypertrophy, Left Ventricular/diagnosis , Hypertrophy, Left Ventricular/etiology , Italy , Male , Middle Aged , Predictive Value of Tests , Referral and Consultation , Risk FactorsABSTRACT
BACKGROUND AND AIM: The impact of aging on the relationship between left ventricular (LV) mass/geometry and diastolic function as assessed by updated echocardiographic methods, such as tissue Doppler, is poorly defined. We investigated this issue in a cohort of hypertensive patients. METHODS: A total of 660 hypertensives (mean age 65 ± 13 years, 48% men) with preserved LV systolic function underwent a comprehensive echo-Doppler examination for routine clinical indications. For the present analysis, the subjects have been divided in two age groups (<65 or ≥65 years). RESULTS: Overall, 61% of subjects fulfilled the criteria for LVH, 18% for left atrial (LA) enlargement and 11% for altered LV filling index. Concentric LV geometry was 1.4-fold higher in older hypertensives than in younger counterparts; also the prevalence of LA enlargement and altered LV filling was 2.0- and 1.9-fold higher in the former group, respectively. In older hypertensives, at variance from younger ones, neither LV mass nor relative wall thickness (RWT), a continuous index of LV geometry, were independently correlated to conventional as well as tissue Doppler LV diastolic indexes. CONCLUSIONS: Our findings suggest the relationship between cardiac hypertrophy and diastolic function in hypertensive subjects is affected by aging-associated factors unrelated to the amount of LV mass as assessed by standard echocardiography.
Subject(s)
Heart Ventricles/physiopathology , Hypertension/physiopathology , Hypertrophy, Left Ventricular/physiopathology , Adult , Age Factors , Aged , Body Mass Index , Diastole , Echocardiography, Doppler , Female , Heart Ventricles/diagnostic imaging , Humans , Hypertension/complications , Hypertension/diagnostic imaging , Hypertrophy, Left Ventricular/complications , Hypertrophy, Left Ventricular/diagnostic imaging , Male , Middle Aged , Stroke Volume , Ventricular Function, LeftABSTRACT
BACKGROUND: The influence of gender on the association between metabolic syndrome (MS) and subclinical organ damage (OD) has been poorly investigated. The aim of this study was to investigate whether the risk of developing left ventricular hypertrophy (LVH) and carotid atherosclerosis is different in men and women with MS. METHODS: A total of 3752 untreated and treated hypertensive patients (mean age 53.3 ± 12.6, 52.7% men) were considered for this analysis. All patients underwent standard ultrasonographic investigations searching for LVH and carotid atherosclerosis. The MS was defined according to ATP III criteria. RESULTS: LVH was more prevalent in women and men with the MS compared with their counterparts (58% vs 34% and 48% vs 33%, respectively, p < 0.001). This was also the case for carotid plaque prevalence (61% vs 42% and 57% vs 44%, p < 0.001). The prevalence of OD was not different between men and women with MS, after adjusting for confounders. In multivariate analysis, abdominal obesity was the most important MS component independently related to LVH in both genders, followed by blood pressure. As for carotid plaques, blood pressure, hyperglycemia and hypertriglyceridemia turned out to be independent correlates regardless of gender. CONCLUSIONS: Our data indicate that MS is associated with a higher risk of LVH and carotid atherosclerosis irrespective of gender; these findings do not support a gender influence in the association between MS and subclinical OD.